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ABSTRACT
Staufen is a dsRNA-binding protein involved in many aspects of RNA regulation, such as mRNA transport, Staufen-medi-
ated mRNA decay and the regulation of mRNA translation. It is a modular protein characterized by the presence of con-
served consensus amino acid sequences that fold into double-stranded RNA binding domains (RBDs) as well as
degenerated RBDs that are instead involved in protein–protein interactions. The variety of biological processes in which
Staufen participates in the cell suggests that this protein associates with many diverse RNA targets, some of which
have been identified experimentally. Staufen binding mediates the recruitment of effectors via protein–protein and pro-
tein–RNA interactions. The structural determinants of a number of these interactions, as well as the structure of full-length
Staufen, remain unknown. Here, we present the first solution structuremodels for full-length hStaufen155, showing that its
domains are arranged as beads-on-a-string connected by flexible linkers. In analogy with other nucleic acid-binding pro-
teins, this could underpin Stau1 functional plasticity.
Keywords: SAXS; Staufen; dsRNA-binding domain; structural biology
INTRODUCTION
Staufen (Stau) is a dsRNA-binding protein originally identi-
fied inDrosophilamelanogaster, where it plays an essential
role in oocyte development (Schupbach and Wieschaus
1986; St Johnston et al. 1991). It is well conserved from
nematodes to humans and, depending on the species, is
composed of four or five dsRNA-binding domains (RBDs)
(Wickham et al. 1999). In humans, there are two Staufen
paralogs: hStau1 and hStau2, each present in several iso-
forms (Park et al. 2013). Much of our knowledge on human
Stau1 is based on the studyof isoform hStau155. hStau155 is
associated with 40S and 60S ribosomal subunits and colo-
calizes with the rough endoplasmic reticulum (Marión et al.
1999; Wickham et al. 1999; Luo et al. 2002). hStau155 has
also been characterized biochemically in the context of
mRNA decay (Kim et al. 2005) and cell cycle control
(Boulay et al. 2014). While Stau2 is expressed primarily in
the neuromuscular system and is mostly involved in
mRNA transport at particular sites of thepost-synapticmus-
cles, Stau1 is ubiquitously expressed (Bélanger et al. 2003;
Lebeau et al. 2008; Vessey et al. 2008; Ravel-Chapuis et al.
2012; Peredo et al. 2014). Even though Stau1 and Stau2
exhibit different tissue expression patterns, they have
been shown to be involved in the same mechanisms of
RNA regulation, such as mRNA transport (Martel et al.
2006, 2010; Ramasamy et al. 2006; Vessey et al. 2008;
Ravel-Chapuis et al. 2012), Staufen-mediatedmRNAdecay
(SMD) (Kim et al. 2005, 2014; Gong et al. 2009; Gong and
Maquat 2011; Cho et al. 2012; Baker et al. 2013; Park and
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Maquat 2013) and regulation of mRNA translation (Ravel-
Chapuis et al. 2012; Bonnet-Magnaval et al. 2016), myo-
genic differentiation (Ravel-Chapuis et al. 2014), stress
granule formation(Ravel-Chapuis et al. 2016), regulation
of adipogenesis (Cho et al. 2012; Baker et al. 2013), pro-
gression of the cell cycle (Boulay et al. 2014), and cellular
differentiation (Gautrey et al. 2005, 2008; Kretz 2013;
Peredoet al. 2014). Theyalso arecentral players in virology,
functioning in HIV infection by favoring viral RNA (vRNA)
encapsidation (Mouland et al. 2000; Chatel-Chaix et al.
2004, 2008; Banerjee et al. 2014), in hepatitis C infection
by transporting vRNA to the site of translation, in the repli-
cationof cellularDNA (BlackhamandMcGarvey2013;Dixit
et al. 2016) and as requirements for efficient influenza A vi-
rus propagation (de Lucas et al. 2010). The variety of cellu-
lar processes in which Stau1 is implicated suggests that it
might adopt different binding modes with its diverse
RNA targets and that structurally distinct RNA–Stau1 com-
plexes mediate the recruitment of effectors via protein–
protein and/or protein–RNA interactions.
Interactions between Stau1 and its RNA substrates
were initially characterized for hStau155. Multiple copies
of hStau155 can bind a single dsRNA. In cells, Stau1 binds
intramolecular duplexes within the hARF1 mRNA (Martel
et al. 2010). Furthermore, in vitro, multiple copies of
Stau1 bind to mRNAs containing as many as 250 CUG re-
peats (Ravel-Chapuis et al. 2012). Additionally, the finding
that hStau155 stabilizes imperfectly base-pairings formed
between mRNAs and lncRNAs (Gong and Maquat 2011),
suggests that multiple hStau1 molecules bind to the
same dsRNA. Genome-wide analysis (Furic et al. 2008;
Laver et al. 2013) and hiCLIP (RNA hybrid and individual-
nucleotide resolution ultraviolet cross-linking and immu-
noprecipitation) (Fernandez Moya and Kiebler 2015;
Sugimoto et al. 2015) of Stau-associatedmRNAs identified
secondary structures that confer binding specificity (Ricci
et al. 2014). Nevertheless, what defines a Stau binding
site remains unclear (de Lucas et al. 2014).
Stau proteins are characterized by two conserved con-
sensus amino acid sequences that fold into dsRNA-binding
domains (RBD3 and RBD4); hStau1 contains two other
RBDs (RBD2 and RBD5) that are unable to bind RNA and,
relative to hStau1, hStau2 has an additional RBD1 and
only a partial RBD5 (Buchner et al. 1999; Wickham et al.
1999; Duchaine et al. 2002; Allison et al. 2004; Furic et al.
2008). hStau1 and hStau2 tubulin-binding domains
(TBDs), which are involved in mRNA transport on the cyto-
skeleton, share only 18% identity. Functional activation of a
number of dsRNA-binding proteins requires that they self-
associate or associate with other dsRNA-binding proteins
(Park et al. 2013). A Staufen swapping motif (SSM) has
been identified to reside between TBD and RBD5. The
SSM is necessary for the homodimeric or heterodimeric in-
teractions between Stau1 and Stau2 (Park et al. 2013). This
dimerization is critical for SMD (Martel et al. 2010;
Gleghorn et al. 2013; Park et al. 2013). The amino-terminal
α-helix of RBD5 was also identified as the major determi-
nant for protein–protein interaction in vivo, intercalating
with the two α-helices of the SSM. A recent SEC-MALLS re-
port on purified protein also showed that, in the absence of
RNA, SSM–RBD5 promotes dimerization (Lazzaretti et al.
2018). The importance of RBD2 in dimerization is less clear.
BRET assays, aimed at the study of hStau155 multimeriza-
tion, show that RBD2 (amino acids 37–79 of isoform
hSTAU155) interacts with full-length hStau1 (Martel et al.
2010). On the other hand, recombinant purified hStau1-
“RBD”2-RBD3 suggests that the contribution of RBD2 to
hStau155 dimerization, while existing, is relatively minor
(Martel et al. 2010; Park et al. 2013).
To date, analyses of the three-dimensional structure of
Stau proteins have focused on studies of truncated ver-
sions of the protein, either in isolation or in complex with
short RNA sequences or in complex with truncated ver-
sions of interacting proteins. The NMR structure of
Drosophila RBD3 first confirmed that this construct is orga-
nized in the typical α-β-β-β-α fold (PDB ID: 1STU) (Bycroft
et al. 1995). Mouse Stau2 RBD4, in the absence of
dsRNA, also showed the α-β-β-β-α fold (PDB ID: 1UHZ).
The structure of human Stau1 SSM–RBD5 solved by X-
ray crystallography revealed a domain swapped dimer,
which is responsible for mediating hStau1 dimerization
(PDB ID: 4DKK) (Gleghorn et al. 2013). The X-ray crystal
structure of the complex between Miranda and RBD5
showed two RBD5s symmetrically bound to the Miranda
dimeric coiled-coil region through their exposed β-sheet
faces, revealing a previously unrecognized protein interac-
tion mode for RBDs (PDB ID: 5CFF) (Jia et al. 2015).
The solution structure of Drosophila melanogaster Stau
RBD3 bound to a 12-bp stem–loop RNA, determined by
NMR spectroscopy, revealed the interaction of the canon-
ical α-β-β-β-α RBD fold with dsRNA (PDB ID: 1EKZ) (Ramos
et al. 1999, 2000). The crystallographic structure of the
RBD3–RBD4 construct, bound to dsRNA as a dimer (mono-
mers A and B), shows that the interaction surface with the
RNA spans the major groove and the two adjacent minor
groove surfaces. Furthermore, RBD3 from monomer B is
bound on the opposite side of the RNAmolecule, in an an-
tiparallel orientation to RBD3A, whereas density for the sec
RBD4 ismissing (Lazzaretti et al. 2018). Human,Drosophila,
and Caenorhabditis elegans Stau bind dsRNA without ap-
parent sequence specificity in vitro (St Johnston et al. 1992;
Marión et al. 1999;Wickhamet al. 1999; Ramos et al. 2000;
LeGendre et al. 2013;Wang et al. 2015). Bono and cowork-
ers recently showed that, in addition to the interactionswith
the sugar-phosphate backbone previously identified for
RBD3 (Ramos et al. 2000), both domains of hStau1 directly
contact RNA bases in theminor groove of the dsRNAused.
Indeed, they also show that specific base recognition is
relevant in vivo andmay therefore contribute to the overall
sequence selectivity by Stau, possibly together with
Visentin et al.
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additional regions of the protein or with other regulators
(Lazzaretti et al. 2018). The macromolecular interaction
events that happen downstream from Stau RNA binding
are still structurally unknown.
We used an integrated structural biology approach,
combining homology modeling, small-angle X-ray scatter-
ing (SAXS), NMR, and hydrodynamic methods to charac-
terize the structure of the human full-length Staufen1
protein. To interpret this structure, we also studied an
hStau155_ΔRBD2 truncated variant, individual hStau155
domains, and several tandem multidomain Stau1 frag-
ments. We confirmed that the deletion of RBD2 influences
the oligomeric state of the protein, as well as reporting for
the first time its effect on protein solubility. Our data show
for the first time that hStau155 adopts an elongated confor-
mation in solution. Furthermore, in the absence of RNA,
RBD3 and RBD4 are connected by a linker that is very flex-
ible in solution, and they do not interact with one another.
The reshaping or folding of flexible components in the
presence of target nucleic acid in proteins has already
been linked to multifunctionality. As an example, DNA
and RNA nucleases (Tsutakawa et al. 2014) behave like
molecular level transformers that can rebuild themselves
by sometimes altering their protein conformations and
typically sculpting the nucleic acid to control both their
specificity and efficiency functions. We propose that the
extreme flexibility and the independent movement of indi-
vidual domains could also be the basis for the functional
plasticity of Stau1 protein: Different relative movements
of domains on themselves and/or on RNA can create mul-
tiple joint recognition surfaces, reshaping itself to elicit
diverse RNA metabolism tasks.
RESULTS AND DISCUSSION
RBD2 influences both solubility and oligomeric state
of Staufen1
Stau proteins were purified to homogeneity by immobi-
lized nickel chromatography followed by size exclusion
chromatography. Additive screening to determine condi-
tions that would allow the protein to achieve high concen-
tration and good homogeneity for subsequent structural
studies was performed using 10 K MWCO spin-concen-
trators (Rambo 2017). The addition of L-Arg HCl to the
buffer proved necessary for maintaining the solubility of
the full-length protein to enable further experiments.
Interestingly, the solubility of hStau155_ΔRBD2 is not af-
fected by the presence (or absence) of L-Arg HCl in the
buffer. However, this additive was used for all constructs
for consistency with the purification requirements of
hStau155_FL. Size exclusion chromatography (SEC) traces
show that the hydrodynamic volumes of hStau155_FL and
of hStau155_ΔRBD2 (∼130–140 kDa) are higher than ex-
pected for globular proteins with correspondingmolecular
weights, suggesting that the two proteins might have an
elongated shape or might form homomultimers. The do-
mains organization of hStau155_FL and hStau155_ΔRBD2
is shown in Figure 1A. SEC-MALS analysis of hStau155_FL
(Fig. 1B) shows thepresenceofmultiple assemblies. In con-
trast to the recently published SEC profile for hStau163_FL
(Lazzaretti et al. 2018), both SEC profiles for hStau155_FL
and hStau155_ΔRBD2 described in this study present
symmetrical peaks. MALS analysis of the eluting species
highlights the different behavior of hStau155_FL and
hStau155_ΔRBD2. Measurements were performed at three
different concentrations (20, 100, and 200 μM). The sam-
ples used for this analysis had not been subject to the
final SEC purification, hence small amounts of species
other than hStau155_FL and hStau155_ΔRBD2 were seen
to be present. However, the predominant peak in the
hStau155_ΔRBD2 sample had a molecular weight consis-
tent with that of a monomer (Fig. 1C). The main SEC peak
for hStau155_FL appears with a molecular weight consis-
tent with a dimer but the high polydispersity seen across
the peak suggests that this is an equilibrium species be-
tween a monomer and higher order oligomers. This is con-
sistent with the previous observation that RBD2 mediates
hStau155_FL self-association (Martel et al. 2010; Lazzaretti
et al. 2018), showing that its presence is fundamental for
the formation of a stable oligomer in solution. The recent
report describing hStau163 did not contain SEC-MALS
analysis for the full-length protein (Lazzaretti et al. 2018).
To resolve the oligomeric assemblies of the species elut-
ing in themain SECpeak,weperformedanalytical ultracen-
trifugation (AUC) experiments. AUC analysis of the peak
fraction from hStau155_FL SEC (Fig. 1D) confirms the coex-
istence of a number of species withmolecular weights con-
sistent with that of themonomer (major species in solution)
and higher oligomers. Measurements were performed at
three different concentrations (4, 25, and 100 μM). We
chose to analyze awide range of concentrations to address
the role of concentration in the oligomeric state of the pro-
tein. The number of oligomers increases with increasing
sample concentration, and the position of the peaks also
shifts to a higher sedimentation coefficient. Both of these
phenomena indicate concentration-dependent self-asso-
ciation equilibrium for hStau155_FL. On the other hand,
both SEC-MALS (Fig. 1C) and AUC (Fig. 1E) analysis of
hStau155_ΔRBD2 show that the truncated protein is only
present in solution as monomer.
Staufen adopts distinct elongated structures
in solution
The first indication that Staufen protein and its hStau155_
ΔRBD2 mutant adopt elongated structures in solution is
given by their average hydrodynamic volume, which is
much higher than expected for the estimated molecular
weight of the monomeric protein. This is in agreement
Staufen structure
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with the Rg and Dmax obtained from SAXS measurements
for both the full-length (Rg ensemble=48.11 Å, Dmax en-
semble=155.2 Å) and truncated ΔRBD2 (Rg ensemble=
50.26 Å, Dmax ensemble=166.96 Å) proteins. The higher
Rg and Dmax for hStau1
55_ΔRBD2 can be explained by a
higher degree of conformational heterogeneity in the FL
protein. Importantly, SAXS shows that both these systems
are characterized by a high degree of flexibility, as shown
by their Kratky plot in Figure 2. The three-dimensional
models of hStau155_FL protein and of its truncationmutant
hStau155_ΔRBD2 were obtained by combining homology
modeling analysis and SAXS data. The models obtained
for hStau155_ΔRBD2 show that the protein adopts a range
of conformations (Fig. 2), from highly extended to more
compact, where RBD3 and RBD5 are in closer proximity.
The relative positions of RBD4, TBD, and SSM show only
minor differences among the models obtained, due to
the flexibility of the loops. On the other hand, the high lev-
el of flexibility of the loops between RBD3 and RBD4 and
between SSM and RBD5 seems to be the main factor that
contributes to the coexistence of a more distended and a
more closed conformation of hStau155_ΔRBD2. These
models show that all the individual domains do not coa-
lesce to form a compact structure. The models obtained
for hStau155_FL, represented in Figure 3, showmore inter-
domain flexibility, resulting in the presence of elongated,
as well as more compact, conformations. The major differ-
ences between the coexisting conformations are due to
the disordered loops between RBD2 and RBD3, between
RBD3 and RBD4 and between RBD4 and TBD. Thanks to
the malleability of these linkers, hStau155_FL seems
to be able to transition in solution from more elongated
to more closed conformations, but still not globular.
The structural information gathered from the SAXSmod-
els for hStau155_FL and hStau155_ΔRBD2 were validated
using 2DNMR (Fig. 4). 15N,1H-TROSY spectrawere record-
ed for individual and tandemdomains, aswell as for the full-
length protein and its truncation mutant ΔRBD2. The large
number of peaks in the central area of the spectra of both
hStau155_FL and hStau155_ΔRBD2 indicates the presence
of a large number of amino acids in disordered regions,
this agreeswell with the presenceof long unstructured link-
ers that confer flexibility on theproteins.Moreover, the sim-
ilar lineshapes and lack of significant chemical shift
perturbations between the spectra recorded for individual
and tandem domains (Supplemental Figs. S4, S5) show
A
B
D E
C
FIGURE 1. Architecture and biophysical characterization of Staufen proteins. (A) Domains organization of hStau155_FL and hStau155_ΔRBD2. (B)
SEC-MALS of hStau155_FL at 20, 100, and 200 μΜ. (C ) SEC-MALS of hStau155_ΔRBD2 at 20, 100, and 200 μΜ. (D) Analytical ultracentrifugation
(AUC) of hStau155_FL at 4, 25, and 100 μΜ. (Ε) Analytical ultracentrifugation (AUC) of hStau155_ΔRBD2 at 4, 25, and 100 μΜ.
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AC D E F
B
FIGURE 2. Small-angle X-ray scattering (SAXS) of Staufen proteins. (A) SAXS intensity curve; (B) Kratky analysis; (C–F ) EOMmodels generated for
hStau155_ΔRBD2 at 60 μΜ [Rg ensemble=50.26 Å, Dmax ensemble=166.96 Å, Rsigma = ∼80.2% (∼85.68%)].
A
C D
E
B
FIGURE 3. Small-angle X-ray scattering (SAXS) of Staufen proteins. (A) SAXS intensity curve; (B) Kratky analysis; (C–E) EOMmodels generated for
hStau155_FL at 40 μΜ [Rg ensemble=48.11 Å, Dmax ensemble=155.2 Å, Rsigma =∼74.45% (∼86.17%)].
Staufen structure
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that any interactions between adjacent domains are very
limited and that each of the domains constituting the
tandem constructs tumbles independently in solution,
thanks to the intervening linkers flexibility. In addition, it
is possible to reconstitute the spectra for hStau155_FL
and hStau155_ΔRBD2 almost entirely by overlaying those
obtained for individual domains, showing that the domains
tumble independently in the full-length protein.
Together, our data suggest that hStau155 is an extremely
flexible protein and its domains can adopt several posi-
tions relative to each other, without interdomain interac-
tions. Thanks to the flexibility of the linkers, the protein
adopts an elongated conformation in solution and its do-
mains behave as beads on a string. Connector regions
are crucial players in Staufen allostery and conformational
changes, in line with recent studies on the role of the
dynamic linker in the modulation of protein function
(Papaleo et al. 2016).
Linker flexibility mediates RBD3 and RBD4
rearrangement
The fitting of a representative subset of SAXS models for
individual or tandem domains in the SAXS models of
A B
C D
FIGURE 4. NMR analysis of Staufen proteins. (A) NMR spectra of hStau155_FL. (B) NMR spectra of hStau155_DRBD2. (C ) Reconstitution of
hStau155_FL spectra by overlapping of RBD2, RBD3–RBD4, and TBD–SSM/RBD5 NMR spectra. (D) Reconstitution of hStau155_DRBD2 spectra
by overlapping of RBD2, RBD3–RBD4, and TBD–SSM/RBD5 NMR spectra.
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hStau155_ΔRBD2 and hStau155_FL is shown in Figures 5, 6,
respectively. The SAXS data and models obtained for in-
dividual and tandem domains are shown in Supplemental
Figures S6–S14. A representative subset of solution scat-
tering models of individual and tandem domains (Fig. 5B)
was chosen in order to interpret the domains rearrange-
ment observed in the models corresponding to the differ-
ent conformations that hStau155_ΔRBD2 adopts in
solution (Fig. 5A). From the fitting proposed in Figure
5C, it is possible to observe that in hStau155_ΔRBD2
the linker connecting RBD3 to RBD4 can be completely
or partially distended. SAXS models obtained for the
construct RBD3–RBD4 well describe the behavior of
these two domains also when they belong to the truncat-
ed protein, showing that the presence of TBD and SSM/
RBD5 does not have a great impact on RBD3–RBD4 rear-
rangements. On the contrary, the models obtained for
the construct RBD3–RBD4 cannot be used for the inter-
pretation of domains rearrangements in hStau155_FL
(Fig. 6A) and a different subset of solution scattering
models (Fig. 6B) needs to be used in the fitting to
describe the conformational changes of the full-length
protein (Fig. 6C). In fact, the solution models obtained
for the tandem domain RBD3–RBD4 (Supplemental Fig.
S11) show that a long linker, which is extremely elongat-
ed, connects these two domains. On the other hand, our
hStau155_FL models show the coexistence of three main
conformations in the solution for which it is interesting to
notice the relative movement of RBD3 and RBD4 and
their closer proximity, possibly in order to elicit the bind-
ing of RNA targets (Fig. 7). In the more elongated model
of the full-length protein (model 1), RBD3 and RBD4 are
in an “open” conformation that resembles the one as-
sumed by the tandem domain on its own. However, in
the other two models (2 and 3), RBD3 and RBD4 are
“pulled” toward each other by conformational changes
of the connecting linker, interestingly resembling the re-
cently deposited structure of the hStau163 RBD3–RBD4
A B C
FIGURE 5. Fitting of SAXS models for Staufen1 domains in the SAXS models obtained for hStau155_DRBD2. (A) EOM models generated for
hStau155_DRBD2. (B) Subset of selected domains and tandem domains models. (C ) Fitting of representative models for domains and tandem
domains in the EOM models generated for hStau155_DRBD2.
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construct bound to dsRNA (Lazzaretti et al. 2018) (repre-
sented in red and blue in Fig. 7).
Taken together, these data show that not only the
presence of RBD2 triggers a spatial reorganization of
RBD3 and RBD4, which is indeed mediated by the linker
between these last two domains, but also the importance
of RBD3–RBD4 relative position and rearrangements on
dsRNA binding. Therefore, we propose that these two do-
mains can change mutual orientation depending on the
structure of the RNA target, in order to effectively bind dif-
ferent substrates in distinct biological contexts. Moreover,
RBDs that are not involved in the binding of RNAs, such
as RBD2 and RBD5, can adopt multiple conformations in
the full-length protein, not only to elicit protein dimeriza-
tion, but also to regulate hStau1 structural plasticity and
multifunctionality in vivo. All in all, our solution studies
demonstrate that Stau protein can adopt several confor-
mations thanks to long linkers that facilitate domains rear-
rangements, providing a clue on the structural background
for the role of Stau in multiple biological pathways. This
would be reminiscent of the remodeling of flexible compo-
nents in the presence of target nucleic acid, which has
been seen in other DNA and RNA binding proteins
(Tsutakawa et al. 2014) that can change overall shape by
altering their protein conformations to switch among their
multiple functions.
Conclusions
Canonical RBDs are composed of an α-β-β-β-α secondary
structure that folds in three dimensions to recognize
dsRNA. Recently, structural and functional studies of diver-
gent RBDs revealed adaptations that include intra- and/or
intermolecular protein interactions, sometimes in the ab-
sence of detectable dsRNA-binding ability (Krovat and
Jantsch 1996; Gleghorn and Maquat 2014). The number
of canonical RBDs per polypeptide is highly variable in
RBD-containing proteins, ranging from one to five
(Macrae et al. 2006; Barraud and Allain 2012; Thomas
and Beal 2017). There is no clear correlation between the
number of RBDs and dsRNA-binding affinity. Moreover,
the extent of the contribution of specific RBDs to RNA
substrate specificity is still an open question. Structural
information reported on dsRBPs carrying one or more ca-
nonical RBD, such as Dicer (Macrae et al. 2006) and
ADARs (Barraud and Allain 2012; Thomas and Beal 2017)
highlights the importance of neighboring domains for sub-
strate specificity and enzymatic activity. Conformational
flexibility of Dicer protein is also proposed to play a central
role in dsRNA recognition and processing (Macrae et al.
2006) and this could be extended to other RBD-containing
proteins, such as hStau1. The lack of structural information
on this protein, for which to date we only had three-
A B C
FIGURE 6. Fitting of SAXS models for Staufen1 domains in the SAXS models obtained for hStau155_FL. (A) EOM models generated for
hStau155_FL. (B) Subset of selected domains and tandemdomainsmodels. (C ) Fitting of representativemodels for domains and tandemdomains
in the EOM models generated for hStau155_FL.
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dimensional models of truncation mutants, in isolation or
in complex with short RNA sequences or truncated protein
interactors (Ramos et al. 1999, 2000; Gleghorn et al. 2013;
Gleghorn andMaquat 2014; Jia et al. 2015; Lazzaretti et al.
2018) made its functional understanding particularly chal-
lenging. Here, we provided for the first time structural in-
formation on the full-length hStau1 protein, using an
integrated structural biology approach. Combination of
hydrodynamic Materials and Materials and Methods, ho-
mology modeling, SAXS and NMR allowed us to show
that Stau1 is a highly flexible protein, that recoils in solu-
tion from an elongated to a compact conformation in
which the domains are in closer proximity but not interact-
ing with each other. In this perspective, we propose that
the flexible interdomain loops possess a regulatory role
in hStau1 activity, allowing a high degree of freedom for
recognition and binding of diverse RNA and protein tar-
gets and for the subsequent involvement of hStau1 in
very diverse aspects of RNA metabolism and regulation.
Interestingly, post-translational modifications have been
identified in loops and linkers regions within hStau1 pro-
tein (Rigbolt et al. 2011; Zhou et al. 2013; Guo et al.
2014), which could be involved in the regulation of do-
mains rearrangement or protein–protein interactions.
FIGURE 7. RBD3 and RBD4 rearrangements in hStau155_FL can explain its plasticity in the binding of diverse dsRNA targets. The SAXS models
obtained for hStau155_FL show that RBD3 (orange) and RBD4 (cyan) transit from an “open” to a “more closed” conformation. A direct comparison
of our models with the crystal structure of the hStau163 RBD3–RBD4 construct bound to Arf1 SBS43 (RBD3 displayed in red and RBD 4 in blue)
shows that RBD3 and RBD4 are “pulled” toward each other by conformational changes of the connecting linker, possibly in order to elicit
dsRNA binding.
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As far as the dimerization of hStau1 is concerned, we
show that this is dependent on the presence of RBD2
and on protein concentration. Consistently with what has
been shown crystallographically, the SSM–RBD5 construct
dimerized in solution (Supplemental Fig. S2). SAXS ex-
periments show that the full-length protein adopts at least
three main conformations in solution, which therefore can
explain its ability to bind diverse RNA targets and protein
partners. Our data provide the first structural insight into
the “Swiss knife” mechanism adopted by the Stau155 pro-
tein to elicit sometimes contrasting biological functions.
MATERIALS AND METHODS
Cloning of individual and tandem domains
for NMR analysis
Individual and tandem hStau155 domains were amplified by PCR
from pRSET-B-Stau155 vector (Kim et al. 2005) as described in
Supplemental Table S1. Purified PCR products and pET28a
were digested with NdeI and HindIIIHF (NEB) for 3 h at 37°C.
Digested vector was purified from 1% agarose gel run in TBE us-
ing the MinElute Gel Extraction Kit (QIAGEN), whereas digested
inserts were purified using the QIAquick PCR Purification Kit
(QIAGEN). Ligations between the vector and the individual inserts
(in ratio 1:3) were performed using theQuick Ligation Kit (NEB) for
5 min at room temperature (RT). Escherichia coli XL1-Blue cells
were transformed by the heat-shock method with 2.5μL of the li-
gation reactions and plated in LB agar plates containing 50 μg/mL
kanamycin. After overnight (o/n), for each of the transformations,
15 mL of LB supplemented with 50 μg/mL kanamycin were inoc-
ulated with a single colony and the cultures were grown at 37°C
o/n. Subsequently, plasmid DNA was purified using the Wizard
Plus SV Minipreps DNA Purification Systems and sequenced.
Protein overexpression and purification for SAXS,
AUC, and EM experiments
Recombinant proteins were overexpressed in E. coli Rosetta
pLysS cells transformed by heat-shock with pRSET-B vectors con-
taining either hStau155_FL (Kim et al. 2005), hStau155_Δ RBD2 or
pET28a containing individual domains (RBD2, RBD3, RBD4, TBD,
SSM/RBD5) or tandem domains (RBD2–RBD3, RBD3–RBD4,
RBD4–TBD, TBD–SSM/RBD5). Starting cultures were grown in
LB medium containing 50 μg/mL ampicillin (for hStau155_FL
and hStau155_ΔRBD2) or 50 μg/mL kanamycin (for individual
and tandem domains) and 34 μg/mL chloramphenicol at 37°C
o/n. Onemilliliter of overnight culture was inoculated in 1 L of ter-
rific broth (TB) medium supplemented with antibiotics and cells
were grown to an 0.6 OD600. Protein overexpression was induced
by adding 0.5 mM IPTG and culturing the cells at 27°C overnight.
Cells were harvested by centrifugation at 5000 rpm on a Beckman
Avanti J-20 XP centrifuge with JLA 8.1000 rotor for 20 min and
washed once with phosphate buffered saline (PBS) solution; cell
pellets were aliquoted and stocked at −80°C. Frozen aliquots
were thawed and lysed by sonication in 20 mL lysis buffer
(25 mM HEPES pH 7.5, 1 M GndCl, 20 mM imidazole, 1%
Triton X-100, 400 μL Complete EDTA-free protease inhibitors
[50X] and 2 μL benzonase) followed by 30 min of incubation on
ice. Soluble protein extracts were separated from cell pellets by
centrifugation at 15,000 rpm for 30min. 6-His tagged hStau1 pro-
teins were purified by nickel chromatography using HisTrap FF
columns (GE Healthcare) equilibrated in washing buffer (25 mM
HEPES pH 7.5, 1 M GndCl, 20 mM imidazole). Elution was per-
formed with 20mM–1M imidazole gradient. Fractions containing
the protein of interest were pooled and concentrated to 10 mg/
mL prior to size exclusion chromatography on Superdex200
(hStau155_FL and hStau155_ΔRBD2) or Superdex75 (individual
and tandem domains) gel filtration columns (GE Healthcare) in
buffer A (25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2,
200 mM L-Arg HCl). Overexpression and purification efficiency
were monitored by SDS–PAGE analysis on 12%, 15%, and 18%
gels stained with SimpleBlue (Life Technologies). Fractions were
also analyzed by western blot; the nitrocellulose membrane was
incubated o/n at 4°C with anti-His antibody conjugated with alka-
line phosphatase (1:4000) and developed using the SIGMA-
FAST BCIP/NBT reagent. Size exclusion chromatography and
SDS–PAGE analysis for hStau155_FL and hStau155_ΔRBD2 are
shown in Supplemental Figure S1, those for individual and tan-
dem domains are shown in Supplemental Figure S2.
Protein overexpression and purification
for NMR analysis
E. coli Rosetta pLysS cells were transformed by heat-shock
with pET-28 vectors carrying inserts for hStau155_FL,
hStau155_ΔRBD2, individual domains (RBD2, RBD3, RBD4, TBD,
SSM/RBD5), and tandem domains (RBD2–RBD3, RBD3–RBD4,
RBD4–TBD, TBD-SSM/RBD5). Starting cultures were grown as
described above and the following d cells were cultured to
OD600=2 in TB medium supplemented with antibiotics. Cells
were harvested by centrifugation at 5000 rpm on a Beckman
AvantiTM J-20 XP centrifuge with JLA 8.1000 rotor for 20 min, re-
suspended in M9 minimal medium (1× M9, 2 mM MgSO4, 0.1
mM CaCl2) and grown for 30 min at 37°C. Successively, the min-
imal medium was supplemented with 400 μL thiamine [50 mg/
mL], filter-sterilized glucose [3 g/L] and filter-sterilized ISOGRO-
15N Powder-Growth Medium [1 g/L]. Protein overexpression
was induced by adding 0.5 mM IPTG and culturing the cells at
27°C overnight. Purification of Staufen proteins was performed
as described above, but replacing HEPES with 20 mM potassium
phosphate buffer pH 7.6 in all buffers used. To prevent the forma-
tion of disulfide bonds, 2 mM Tris(2-carboxyethyl)phosphine hy-
drochloride (TCEP) was added to the purified proteins.
Analytical ultracentrifugation (AUC)
The experiments were performed at 40,000 rpm, using a
Beckman XL-I analytical ultracentrifuge equipped with an An-
50Ti rotor. Data were recorded using both absorbance (at 280
and 260 nm) and interference optical detection systems. The den-
sity and viscosity of the buffer were measured experimentally us-
ing a DMA 5000M densitometer equipped with a Lovis 200ME
viscometer module. The partial specific volume for the protein
was calculated using SEDNTERP from the amino acid sequence.
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Data were processed using SEDFIT, fitting to the c(s) model.
Figures were made using GUSSI (Lebowitz et al. 2002).
SEC-MALS
SEC-MALS experiments were performed using a Superdex 200
10/300 Increase column (GE Healthcare) connected to an
AktaPure 25 System (GE Healthcare). The protein sample (100
μL) was loaded onto the gel filtration column and eluted with
one column volume (24 mL) of buffer A, at a flow rate of 0.7
mL/min. The eluting protein was monitored using a DAWN
HELEOS-II 18-angle light scattering detector (Wyatt Technolo-
gies) equipped with a WyattQELS dynamic light scattering
module, a U9-M UV/Vis detector (GE Healthcare), and an Optilab
T-rEX refractive index monitor (Wyatt Technologies). Data were
analyzed by using the Astra software (Wyatt Technologies) using
a refractive increment value of 0.185 mL/g.
Small angle X-ray scattering and modeling
SAXS data for hStau155_FL and hStau155_ΔRBD2 were collected
at B21, Diamond Light Source (Harwell, UK). Fifty-five microliters
of each protein sample (∼10 mg/mL) were loaded onto a
Superdex200 column (GE Healthcare), controlled by an Agilent
HPLC system, coupled to an in-vacuum SAXS flow cell. HPLC-
SAXS traces were processed using ScÅtter. High-resolution struc-
tures of individual domains were used as rigid bodies and con-
straints in the model generation. In our analysis, the modeled
structures of the individual domains of Staufen1 were obtained
using the Phyre2 web portal (Kelley et al. 2015). Human
Staufen1 RBD3 was modeled by homology based on the NMR
structure of D. melanogaster Staufen RBD3 (PDB ID: 1EKZ)
(Ramos et al. 2000). The structure of human Staufen1 RBD4 was
obtained by homology modeling based on the mouse RBD4
(PDB ID: 1UHZ). The structures of SSM and RBD5, were extracted
from the structure solved by X-ray crystallography (PDB ID: 4DKK)
(Gleghorn et al. 2013) and treated as two separate domains in this
analysis, allowing complete interdomain loop flexibility. To obtain
amore complete set of structural information to use as constraints
for the interpretation of the SAXS data, the sequences of the 6-His
+ linker+RBD2 domain of hStau155_FL, the 6-His + linker of
hStau155_ΔRBD2 and the TBD were modeled using the Phyre2
server (Kelley et al. 2015). The program EOM 2.0 (Tria et al.
2015) was used to obtain the models of hStau155_FL protein
and deletion mutants. A pool of 10,000 independent models
was generated, based on the sequence of hStau155_FL, or
hStau155_ΔRBD2, and on constraints, we generated by homology
modeling. After the creation of the pool of models, EOM (Tria
et al. 2015) runs a genetic algorithm that compares the average
theoretical scattering intensity from the ensemble of 10,000 con-
formations with the experimental scattering data and selects the
models that best describe the experimental data, taking into ac-
count the constraints used as input (in this case, the homology
models of individual domains).
SAXS data for individual domains and tandem domains were
collected at B21, Diamond Light Source (Harwell, UK). Fifty-five
microliters of each protein sample (∼10 mg/mL) were loaded
onto a Superdex75 column (GE Healthcare), controlled by an
Agilent HPLC system, coupled to an in-vacuum SAXS flow cell.
HPLC-SAXS traces were processed using ScÅtter. Data were ana-
lyzed using different strategies depending on their flexibility lev-
el. Models for individual domains RBD3 and RBD4 were obtained
using ScÅtter and DAMMIN and the tandem domain TBD_SSM/
RBD5 was modeled using BUNCH (ATSAS). All the other do-
mains, showing higher degree of flexibility, were modeled with
EOM, as described above.
NMR spectroscopy
hStau155_FL, hStau155_ΔRBD2, individual and tandem domains
were studied by NMR spectroscopy. Thirty microliters of D2O
were added to 570 μL of protein in 20 mM potassium phosphate
pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl, 2mM
TCEP at a suitable concentration for NMR experiments (Supple-
mental Table S2). 15N,1H-TROSY-HSQC spectra (Weigelt 1998)
were acquired at 298 K using a Bruker AVANCE IIIHD 600 MHz
spectrometer equipped with a 5 mm TCI cryoprobe. Data were
processed using the Bruker TopSpin software and figures were
generated using the CCPN analysis 2.4 software (Vranken et al.
2005).
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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